SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-553244
Filing Date
2016-04-25
Accepted
2016-04-25 10:40:39
Documents
4
Period of Report
2016-06-14
Effectiveness Date
2016-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d171778ddef14a.htm DEF 14A 495169
2 GRAPHIC g171778g36g25.jpg GRAPHIC 32563
3 GRAPHIC g171778g83q01.jpg GRAPHIC 25583
4 GRAPHIC g171778pcpg001.jpg GRAPHIC 3834
  Complete submission text file 0001193125-16-553244.txt   581790
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35409 | Film No.: 161588140
SIC: 2834 Pharmaceutical Preparations